Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced that its director of investor relations, Alan Klitenic, was featured in a recent interview with SmallCapVoice.com.
Articles
InMed (CSE: IN; OTCQB: IMLFF) Retains Consultant Ben Paterson for Biosynthesis Development
InMed Pharmaceuticals (CSE: IN, OTCQB: IMLFF) announced today that it has retained the consulting services of Ben Paterson, P.E., to assist in defining the pathway for the scale-up, purification, and manufacturing strategies for InMed’s cannabinoid biosynthesis program.
iAnthus Expands Expert Operations Team with New Hire
iAnthus Capital Holdings, Inc., (CSE: IAN) (CSE: IAN.CN) (CNSX: IAN) (OTCQB: ITHUF), announces the appointment of Carlos Perea as Chief Operating Officer. Mr. Perea's hire adds another highly experienced member to iAnthus' expert operations team
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Retains Consulting Services of Ben Paterson
Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced that it has retained the consulting services of Ben Paterson, P.E., to assist in defining the pathway for scale-up, purification and manufacturing strategies related to the company’s cannabinoid biosynthesis program.
Cannabis Agricultural Biotech Company Front Range Biosciences Raises $3 Million in Bridge Round Funding
Front Range Biosciences announces it has raised $3 million in bridge round funding.
Aurora Begins Supplying German Medical Cannabis Market
Aurora Cannabis Inc. (TSX: ACB) (OTCQX: ACBFF) announced today that it has received all the required permits to ship dried cannabis flower from Canada to Germany.
Emerald Health Therapeutics Expands its Cannabis Supply with Purchase from Supreme Pharmaceuticals
Emerald Health Therapeutics Inc. (EHT) (TSXV:EMH) (OCTQX:EMHTF) today announced that its wholly owned subsidiary, Emerald Health Botanicals Inc., has completed a purchase of dried cannabis from Supreme Pharmaceuticals Inc.’s (TSXV:FIRE) subsidiary, 7ACRES.
PotNetwork Holding, Inc. (POTN) Announces Hurricane Irma Relief Promotion
As part of the ongoing Hurricane Irma relief efforts, Diamond CBD will be donating 10 percent of all net proceeds for the next three days and offering a 50 percent discount storewide.
ChineseInvestors.com, Inc. (CIIX) Subsidiary Completes China FDA Filing; Moves toward Launch of Hemp-Infused Skin Care Line
Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX), through wholly-owned subsidiary CBD Biotechnology Co. Ltd., this morning announced that it has completed the record filing process with the China Food & Drug Administration (“CFDA”) for its first line of non-industrial hemp-infused skin care products.
India Globalization Capital, Inc. (NYSE: IGC) Provides Update on Data Showing Effectiveness of THC in Addressing Underlying Cause of Alzheimer’s
India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning provided an update on compelling in vitro data compiled from genetically engineered cell lines within an Alzheimer’s disease model.
The Green Organic Dutchman Holdings Ltd. Announces Financing Syndicate for $20 Million Offering
he Green Organic Dutchman Holdings Ltd. announces the syndicate for the offering of 4,242,500 Units of the Company at a price of C$1.65 per Unit for aggregate gross proceeds of C$7,000,125.
ABcann Global Receives $11.9 Million from Exercise of Warrants
ABcann Global receives $11.9 Million from the exercise of outstanding warrants.
Copy of ABcann Global Receives $11.9 Million from Exercise of Warrants
ABcann Global receives $11.9 Million from the exercise of outstanding warrants.
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Nets Total Proceeds of $11.9 Million from Exercise of Warrants
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) this morning announced that it has received total proceeds of nearly $11.9 million from the exercise of an aggregate of 19,185,965 warrants since the closing of its acquisition of ABcann Medicinals Inc. on April 28, 2017.
The Bio Pharma Project Generator
StockHouse did an in-depth look at InMed Pharmaceuticals (CSE: IN, OTCQB: IMLFF) about their model, technology and the "Big Picture"